Cheetah Medical

Cheetah Medical was founded in Tel Aviv, Israel in 2001 with the mission of helping clinicians manage their patient’s fluid status. Cheetah was a pioneer in understanding how electrical currents are affected by pulsatile blood flow. The result of this proprietary science was the development of the CHEETAH NICOM® Hemodynamic Management System. The CHEETAH NICOM® system is the world’s leading technology for providing decision support in the management of Cardiac Output and other key hemodynamic parameters. Cheetah Medical is a Delaware corporation with its Headquarters in Boston, Massachusetts. R&D, Finance, Regulatory and Quality Affairs are located in Tel Aviv. Cheetah employs 50 people worldwide, and sells through a direct sales organization in the U.S. while utilizing a network of distributors to reach 20+ countries outside the U.S. 

Cheetah Medical has developed a robust portfolio of clinical data including several peer review studies that document the accuracy and clinical utility of the CHEETAH NICOM® Hemodynamic Monitoring System. With over 110 publications from a global cadre of authors, the CHEETAH NICOM® is an incredibly well documented technology.